Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Jan 6;18(1):e0280133. doi: 10.1371/journal.pone.0280133

Lack of the Ig cell adhesion molecule BT-IgSF (IgSF11) induced behavioral changes in the open maze, water maze and resident intruder test

Dirk Montag 1,*, Laura Pelz 2,¤, Fritz G Rathjen 2
Editor: Jamuna Subramaniam3
PMCID: PMC9821459  PMID: 36607983

Abstract

The brain- and testis-specific Ig superfamily protein (BT-IgSF, also termed IgSF11) is a homotypic cell adhesion protein. In the nervous system, BT-IgSF regulates the stability of AMPA receptors in the membrane of cultured hippocampal neurons, modulates the connectivity of chandelier cells and controls gap junction-mediated astrocyte-astrocyte communication. Here, we performed behavioral tests in BT-IgSF-deficient mice. BT-IgSF-deficient mice were similar to control littermates with respect to their reflexes, motor coordination and gating, and associative learning. However, BT-IgSF-deficient mice displayed an increased tendency to stay in the central illuminated areas in the open field and O-Maze paradigms suggesting reduced anxiety or increased scotophobia (fear of darkness). Although BT-IgSF-deficient mice initially found the platform in the water maze their behavior was compromised when the platform was moved, indicating reduced behavioral flexibility. This deficit was overcome by longer training to improve their spatial memory. Furthermore, male BT-IgSF-deficient mice displayed increased aggression towards an intruder. Our results show that specific behaviors are modified by the lack of BT-IgSF and demonstrate a contribution of BT-IgSF to network functions.

Introduction

Initially BT-IgSF (brain- and testis-specific Ig superfamily protein, also designated IgSF11) was described as a novel IgSF member that is preferentially expressed in the brain and testis BT-IgSF [1]. It functions as a homotypic cell adhesion protein [2, 3] and shares an identical overall domain organization with an N-terminal located V- and a C2-type domain and a highly related amino acid sequence with CAR (coxsackievirus and adenovirus receptor), endothelial cell-selective adhesion molecule (ESAM), and CLMP (CAR-like membrane protein) [4]. Independently, BT-IgSF was also found to be up-regulated in intestinal-type gastric cancers and designated IgSF11 [5] (moreover it was also termed V-set and Immunoglobulin domain containing 3, abbreviated VSIG-3) [3, 6]. The cytoplasmic segment of BT-IgSF contains a PDZ-recognition motif that binds to scaffolding proteins such as PSD95 [7].

So far, the function of BT-IgSF has been studied in neural cells, Sertoli and germ cells of the testes, during osteoclast differentiation and in the organization of pigment cells in fish [2, 714]. In the murine testis BT-IgSF is found in Sertoli cells at the blood-testis barrier, a structure that opens and closes to allow the passage of germ cells. In a global knockout the absence of BT-IgSF causes a malfunction of the blood-testes-barrier due to a mislocalization of connexin43, which was found throughout the seminiferous epithelium instead of being restricted to the blood-testes barrier [9]. In line with this finding connexin43 has been shown to play an essential role in the reassembly of the blood-testes barrier [15]. A critical role of BT-IgSF in regulating the organization of pigment cells into stripes along the dorso-ventral or anterior-posterior body axes was observed in zebrafish and Neolamprologus meeli [2, 11, 12]. Similar irregular patterns of chromatophores have been described in zebrafish with mutations in connexin 41.8 and connexin 39.4 suggesting a functional link between BT-IgSF and connexins [1619].

In the brain, BT-IgSF is strongly expressed in GFAP-positive astrocytes, ependymal cells and more weakly in neurons [14]. Knockdown studies using cultured mouse hippocampal neurons indicated that BT-IgSF (IgSF11) is implicated in synaptic transmission and plasticity through a tripartite interaction with PSD95 and AMPA receptors [7]. In this in vitro experiment, knockdown of BT-IgSF (IgSF11) led to the increased mobility of AMPA receptors and resulted in enhanced endocytosis of AMPA receptors. Therefore, BT-IgSF might be important for the stabilization of AMPA receptors in neuronal plasma membranes [7]. In another study on neurons, BT-IgSF was found to regulate the innervation of pyramidal neuron axon initial segments by chandelier cell axons [8]. More recently, we demonstrated that the absence of BT-IgSF perturbed gap-junction mediated communication between astrocytes in the hippocampus and cortex as shown by biocytin spread. In addition, we found that BT-IgSF-deficient mice displayed a reduction in their expression level of astrocytic connexin43 protein and an impaired clustering of connexin43 [14].

Overall, BT-IgSF expression in the brain may modify the information flow in neuronal or astrocyte networks and as a consequence might affect the behavior. Therefore, we investigated the behavior of BT-IgSF-/- mice using different paradigms. Here, we show that lack of BT-IgSF results in distinct changes in open mazes, spatial orientation and increased male aggression.

Materials and methods

Ethics statement

Animal experiments were in line with the guidelines for the welfare of experimental animals and approved by the local authorities of Sachsen-Anhalt and Berlin (LaGeSO numbers T0313/97, X9007/16, O 0038/08) and carried out in accordance with the European Communities Council Directive of 24th November 1986 (86/609/EEC) and directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.

Mice

BT-IgSF-deficient mice (B6-Igsf11tm1e(KOMP)Wtsi/FGR) and genotyping have been described elsewhere [9]. Heterozygous mice were intercrossed to obtain homozygous mutants and wild type (WT) littermates that served as control. Animals were housed on a 12/12 h light/dark cycle with free access to food and water.

Behavior

For the behavioral analysis, sex- and age-matched wild type littermate mice were used as control. During the light phase (12h/12h light-dark cycle), mice were subjected to a series of behavioral tests by an experimenter not aware of the genotype. The behavior of three independent cohorts of mice was investigated (cohort #1: 6 KO males and 7 WT males; cohort #2: 5 KO males and 6 WT males; cohort #3 6 KO males 6 WT males 6 KO females 6WT females) for each sex and genotype. First, mice were housed singly for at least two weeks and then a resident intruder test as described by [20] was conducted. Followed by a series of tests as described in [2123]. Briefly, after assessment of general parameters indicative of the health and neurological state of the mice, the following behavioral paradigms were conducted in sequential order:

For the resident intruder test, a foreign C57BL/6NCrl age- and weight-matched male was placed into the home cage of the male test mouse. The latencies to first contact and first attack and the number and duration of attacks were determined from video records. The test was terminated after 240 sec.

Grip strength was measured with a high-precision force sensor to evaluate neuromuscular functioning (TSE Systems GmbH, Bad Homburg, Germany).

Rota-rod performance. Animals received two training sessions (3 h interval) on a rota-rod apparatus (TSE) with increasing speed from 4 to 40 rpm for 5 min. After 4 days, mice were tested at 16, 24, 32, and 40 rpm constant speed. The latency to fall off the rod was measured.

Open field. Exploration was assessed by placing mice in the middle of a 50 x 50 cm arena for 15 min. Using the VideoMot 2 system (TSE), tracks were analyzed for path length, visits, walking speed, and relative time spent in the central area (infield), in the area close to the walls (<10 cm, outfield), and in the corners.

O-Maze. Mice were placed in the center of an open area of an O-maze (San Diego Instruments). Their behavior during 5 min was recorded on videotape. Number of entries into the closed or open areas was counted and the time spent in these compartments was determined using the VideoMot 2 system (TSE).

Light-dark Avoidance. Anxiety-related behavior was tested by placing mice in a brightly lit compartment (250 lux, 25 x 25 cm) adjacent to a dark compartment (12.5 x 25 cm). The number of transitions between the compartments and the time spent within each were analyzed during 10 min. As a test for long-term memory [24] animals were placed at the last day of testing again in the light-dark avoidance box. The latency to enter the dark compartment was measured and compared to the latency at the first time in the box.

Acoustic startle response and prepulse inhibition (PPI). A startle stimulus (50 ms, 120 dB) was delivered to the mice in a startle-box system (TSE) with or without preceding prepulse stimulus (30 ms, 100 ms before the startle stimulus) at eight different intensities (73–94 dB, 3 dB increments) on a 70 dB white noise background. After habituation to the box (3 min), 2 startle trials were followed in pseudo-random order by 10 startle trials and 5 trials at each of the prepulse intensities with stochastically varied intertrial intervals (5–30 s). The maximal startle amplitude was measured by a sensor platform.

Associative learning was assessed by two-way active avoidance in a two-chambered shuttle-box (TSE) with 10 s light as conditioning (CS) and electrical foot-shock as unconditioned stimulus (US, 5 s, 0.5 mA pulsed) delivered after the CS (80 trials/ day, 5–15 s stochastically varied intertrial intervals, 5 consecutive days) using mice of cohorts #1 and #3. Compartment changes during CS were counted as conditioned avoidance reactions.

For conditioned fear testing, the experimental protocol used by [2527] was followed closely. Mice of cohort #2, which were not used in the two-way active avoidance shuttle box, were trained and tested on 2 consecutive days. Training consisted of placing the subject in an operant chamber (San Diego Instruments) and allowing exploration for 2 min. Afterwards, an auditory cue was presented for 15 sec with a footshock (1.5 mA un-pulsed) delivered during the last 2 sec of the auditory cue. This procedure was repeated, and mice were returned to the home cage 30 sec later. 24 hours after training, mice were returned to the same chamber in which training had occurred (context), and freezing behavior (immobility) was recorded. At the end of the 5 min context test, mice were returned to their home cage. One hour later, mice were placed in a novel environment and freezing behavior (immobility) was recorded for 3 min. The auditory cue (CS) was then presented for 3 min and freezing behavior (immobility) was recorded. Freezing scores are expressed as percentage for each portion of the test.

To address spatial learning, we used 3 different Water Maze protocols. The water maze consisted of a dark-grey circular basin (130 cm diameter) filled with water (24–26°C, 30 cm deep) made opaque by the addition of white paint. A circular platform (10 cm diameter) was placed 1.5 cm below the water surface. Protocol 1 was used for cohorts #1and #2 in which mice were submitted to 6 trials per day for 5 days. They were allowed to swim until they found the platform or 120s had elapsed. In this last case, animals were guided to the platform and allowed to rest for 10s. The hidden platform remained at a fixed position for the first 3 days (18 trials, aquisition phase) and was moved into the opposite quadrant for the 2 last days (12 trials, reversal phase). Trials 19 and 20 were defined as probe trials to analyze the precision of the spatial learning. All trials were videotaped and analyzed using the VideoMot 2 system (TSE) and the Wintrack analysis software (release 2000). Protocol 2 was used for cohort #2 after all other tests were finished. Mice were submitted to 4 trials per day for 2 days. They were allowed to swim until they found the platform or 60s had elapsed. The hidden platform was placed at the same position as during acquisition after protocol 1 for the first 8 trials, followed by a trial without platform (probe trial 1) and was then moved into the opposite quadrant for 2 more days (8 trials, reversal), and finally followed by a trial without platform (probe trial 2). Protocol 3 was used on cohort #3 and lasted 10 days with 4 trials (maximum 60 sec) per day for 2 days, followed by a trial without platform (probe trial 1), again 4 trials per day for 2 days and probe trial 2, and again 4 trials per day for 2 days and probe trial 3. Afterwards the hidden platform was placed at a different position every day (opposite, left, right quadrant, and center) for 4 days with 4 trials followed by a daily probe trial.

Statistical analysis

Behavioral data were analyzed using analysis of variance (ANOVA with genotype and sex as factors) and post hoc analysis using Scheffe’s test (Statview Program, SAS Institute Inc., Cary, NC) to determine statistical significance. For the rota-rod, open field, and startle/PPI experiments, statistical analysis was additionally performed using repeated measures ANOVA (with between-subject factor genotype and within-subject factor session). A P-value smaller than 0.05 (p<0.05) was considered significant.

Results and discussion

Behavioral analysis of BT-IgSF-deficient mice

To investigate potential behavioral deficits in mice lacking BT-IgSF, BT-IgSF-deficient mice (KO) and wild type littermates (WT) were subjected to a series of behavioral tests. During the neurological examination, transgenic mice did not display obvious abnormalities with respect to body posture, reflexes (uprighting, eye-blink), or general sensory perception (vision, hearing, touch, pain). As expected, body weight differed significantly between male and female mice (2-way ANOVA Fsex(1,44) = 21.263, p<0.0001), but not between genotypes (KO males (n = 17) 28.0±0.7 g, WT males (n = 19) 29.2±0.7 g; KO females (n = 6) 24.1±0.4 g, WT females 24.8±0.9 g). Likewise, the maximum and average grip strength were significantly higher for males compared to females (2-way ANOVA Fsex(1,20) = 12.794, p = 0.0019; Fsex(1,20) = 12.228, p = 0.0023, respectively, cohort #3 24 mice n = 6 for each sex and genotype), but did not differ between BT-IgSF-deficient and control mice. Furthermore, motor coordination examined on the Rota-Rod was similar for BT-IgSF-deficient and control mice (Fig 1A), indicating that coordination is not generally impaired in adult BT-IgSF-deficient mice.

Fig 1. Behavioral assessment of BT-IgSF-deficient mice.

Fig 1

BT-IgSF-deficient mice and control wildtype littermates were subjected to a series of behavioral paradigms. Motor coordination tested on the rotarod (A) did not differ between BT-IgSF-deficient (black columns) and control mice (white columns). In the open field (B) BT-IgSF-deficient mice (black column) stayed significantly longer in the center compared to their wild-type littermates (white column). In the O-Maze (C) BT-IgSF-deficient mice (black columns) spend more time in the open areas compared to littermate controls (white column). In the two-way active avoidance shuttle box paradigm (D) BT-IgSF-deficient (black line) and control mice (grey line) showed similar acquisition of the task as measured by conditioned responses indicating normal associative learning. Prepulse inhibition of the startle response (E) was not affected in BT-IgSF-deficient mice (black squares) in comparison to wild type littermates (grey bullets). Male BT-IgSF-deficient mice (black column) displayed increased aggression in the intruder test (F) compared to controls (white column) measured by the number of attacks.

In the open field test, BT-IgSF-deficient mice spent significantly more time in the center compared to control littermates (Fig 1B; 1-way ANOVA F(1,46) = 7.374, p = 0.0093; KO (n = 23) 275.0±30.9 sec, WT (n = 25) 185.2±14.1 sec). Furthermore, the distance travelled by BT-IgSF-deficient mice in the wall regions of the maze was significantly shorter (1-way ANOVA F(1,46) = 7.448, p = 0.009, KO (n = 23) 44.6±3.0 m; WT (n = 25) 54.7±1.9 m). These behavioral differences may indicate reduced anxiety, increased scotophobia, or increased explorative activity in BT-IgSF-deficient animals.

In the light-dark avoidance paradigm, BT-IgSF-deficient mice (n = 22) made fewer transitions (14.7±2.1) between compartments, spent more time (338.6±36.5 sec) in the illuminated compartment, and entered the dark compartment after longer latency (207.6±37.3 sec) compared to WT mice (n = 25, 19.9 ±2.6 transitions; illuminated 283.8±30.5 sec; latency 183.6±33.9 sec). However, these differences were not statistically significant. When tested for memory, BT-IgSF-deficient mice and control littermates both showed reduced latencies to enter the dark compartment in comparison to the first exposure to the box, which indicates formation of long-term memories independent of the genotype. Still, BT-IgSF-deficient mice took longer to enter the dark compartment when compared to control littermates (BT-IgSF-deficient 167.7±50.4 sec; WT 118.0±39.2 sec, not significant).

In the O-Maze, BT-IgSF-deficient mice spent significantly longer time in the open areas (Fig 1C, 1-way ANOVA F(1,40) = 7.205, p = 0.0105, KO (n = 20) 77.7±5.1% of time, WT (n = 22) 56.7±5.8% of time) and moved similar distances in the open, but less in the closed areas as compared to control littermates (distance closed 1-way ANOVA F(1,40) = 6.565, p = 0.0143, KO (n = 20) 4.44±0.98m, WT (n = 22) 8.18±1.07m). In summary, BT-IgSF knockout mice spend more time in the open illuminated areas in these mazes.

In the two-way active avoidance shuttle box paradigm, the learning curve as measured by the number of conditioned responses was similar for BT-IgSF-deficient and WT control mice (Fig 1D) indicating that associative learning e.g., the association of the light signal and the footshock was not compromised in BT-IgSF-deficient mice.

When their startle response and pre-pulse inhibition was analyzed, BT-IgSF-deficient mice displayed a slightly but not significantly reduced startle response at 120 dB (1-way ANOVA F(1,46) = 2.997, p = 0.0901) which was inhibited by pre-pulses of intensities between 73 and 94 dB similar as for WT mice (Fig 1E). These results support that auditory perception, sensorimotor gating and processing are not altered in BT-IgSF-deficient mice.

Fear conditioning was analyzed using mice from cohort #2 mice that were not subjected to the shuttle box. No significant differences between BT-IgSF-deficient (n = 5) and WT (n = 6) male mice with respect to freezing in the context or in the neutral environment with or without tone were detected (). Likewise, context memory (% freezing context—% freezing neutral) and tone memory (% freezing with tone in neutral—% freezing neutral without tone) were not significantly different in BT-IgSF-deficient compared to control mice. These data support the normal formation of associative memories observed in the shuttle box test.

BT-IgSF-deficient mice were further investigated in the Morris Water maze for the acquisition and flexibility of their spatial memory. First, cohort #1 and 2 were subjected to water maze protocol 1 with acquisition for 18 trials over 3 days (D1-3), followed by moving the position of the platform for the next 12 trials over 2 days (D4-5). BT-IgSF-deficient mice displayed similar acquisition (D1-3) as WT mice with respect to escape latency (Fig 2A) and path length (Fig 2B). After platform reversal (D4-5) BT-IgSF-deficient mice differed significantly from WT showing longer escape latencies caused by longer times of immobility (Fig 2C). To further investigate the flexibility of their spatial memory, cohort #2 was subjected to water maze paradigm 2 (Fig 2D–2G). Acquisition during 8 trials (D1-2) was followed by 1 probe trial without platform. For the reversal, the platform was moved to a new position for 8 trials (D3-4) followed by a second probe trial without the platform. Again, BT-IgSF-deficient mice showed longer escape latencies but similar path length after replacing the platform (Fig 2D and 2E). Notably, WT but not BT-IgSF-deficient mice established a quadrant preference (>25% of time) for the goal quadrant displayed in probe trial 1 (Fig 2F). In probe trial 2, the preference for the new goal quadrant was similar for BT-IgSF-deficient and wild type mice (Fig 2G). To investigate their spatial learning further, a third water maze protocol was conducted with cohort #3 (Fig 3). Escape latencies (Fig 3A) and path length (Fig 3B) were similar for WT and BT-IgSF-deficient mice. However, in this protocol the establishment of goal quadrant preferences was used an indicator for spatial learning and was assessed by 3 probe trials (probe 1–3) during the acquisition phase and 1 probe trial after each platform position shift (probe 4–7) (Fig 3C). WT mice established a goal quadrant preference after 12 trails (probe 1), whereas BT-IgSF-deficient mice required 20 trials (probe 2). Only after 24 trials (probe 3), BT-IgSF-deficient mice displayed similar preference and quadrant distinction as WT mice. During the reversal trials, escape latency, path length, and quadrant preferences for WT and BT-IgSF-deficient mice were similar. Therefore, after a longer 6 day training and pronounced acquisition period, BT-IgSF-deficient mice mastered the task similarly well as their control littermates. In conclusion, BT-IgSF-deficient mice required more training to establish a robust spatial memory and displayed subtle deficits in the flexibility of the spatial memory when challenged with changing platform positions.

Fig 2. Spatial learning of BT-IgSF-deficient mice in the water maze.

Fig 2

In the water maze protocols 1 (A-C) and 2 (D-G) with short acquisition phase, BT-IgSF-deficient (black line) showed similar escape latencies (A, D) and pathlengths (B, E) during acquisition but needed much longer time after the platform was moved to a different position compared to littermate controls (grey line). This was mainly caused by longer times of immobility (C). Whereas control mice (white columns) established a goal quadrant preference (F) quickly, BT-IgSF-deficient mice (black columns) did not establish a significant preference for the goal quadrants (F, G). Yellow line indicates chance level 25% in F (probe trial 1) and G (probe trial 2).

Fig 3. Flexibility in spatial learning of BT-IgSF-deficient mice in the water maze.

Fig 3

To investigate, whether longer training improved spatial learning in BT-IgSF-deficient mice, the water maze protocol 3 was conducted. During this long acquisition phase and reversals, the escape latencies (A) and pathlengths (B) of BT-IgSF-deficient (black line) and control littermate mice (grey line) did not differ significantly contrasting the compromised flexibility after short acquisition (Fig 2). The evaluation of the goal quadrant preferences during the interspersed probe trials (C) revealed that control littermate mice (white columns) had established a preference already after 12 trials (probe 1) whereas BT-IgSF-deficient (black columns) required 20 trials (probe 3). After changing the platform position daily, quadrant preferences of BT-IgSF-deficient and controls were similar (probe 4–7).

During handling of male BT-IgSF-deficient mice, a slightly increased aggressive behavior was observed. Therefore, male BT-IgSF-deficient mice were subjected to a resident intruder test which revealed a significantly increased number of attacks by BT-IgSF-deficient mice compared to WT (1-way ANOVA F(1,34) = 4.178, p = 0.0488; KO n = 17, 3.5±0.9 attacks, WT n = 19, 1.4±0.6 attacks, Fig 1F) accompanied by shorter latency to attack (KO 142.7±19.6 sec; WT 185.1±18.3 sec).

Conclusions

In the present study, we identified significant behavioral differences between BT-IgSF-deficient and control mice. In several paradigms, we observed that BT-IgSF-deficient mice prefer central illuminated areas compared to controls. This may be interpreted as an indication of reduced anxiety, or alternatively as an increased fear of the dark, or altered explorative behavior. Furthermore, we identified a reduced flexibility to adjust for changes in the platform location in water maze paradigms and observed increased aggressive behavior in BT-IgSF-deficient mice.

BT-IgSF is expressed by neurons and astrocytes in the developing, as well as mature nervous system [7, 14, 28]. Functional studies on BT-IgSF (IgSF11) in neurons showed that it regulates the localization of AMPA receptors. Binding of BT-IgSF to the scaffolding protein PSD95 ensures its localization to excitatory neurons that also stabilizes AMPAR receptors at synapses. Knockdown of BT-IgSF mRNA in neuronal cultures increased AMPA receptor mobility in neurons as measured by high-throughput single molecule tracking. Consequently, BT-IgSF deletion in mice resulted in a suppression of AMPA receptor-mediated synaptic transmission in the dentate gyrus and long-term potentiation in the CA1 region of the hippocampus [7]. Furthermore, functional studies on BT-IgSF in astrocytes indicated a severe defect in gap junction mediated astrocyte-astrocyte coupling, while a global BT-IgSF knockout led to an increase in connexin43 clustering and a decrease in dye spread via gap junctions in the cortex and hippocampus. These data indicate that BT-IgSF is essential for correct gap junction-mediated astrocyte-astrocyte communication [14]. Overall, we conclude that BT-IgSF expression in neurons and astrocytes may interfere with information flow in neuronal or astrocyte networks and as a consequence might modulate the network properties influencing behavioral performance. However, the contribution of each of these communication defects measured in neurons or in astrocytes lacking BT-IgSF to behavior remains to be determined by future research.

The observed aggressive behavior might be due to change in the hormonal balance in the hypothalamic-pituitary axis in the absence of BT-IgSF. However, differences in blood levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), or testosterone were not detected between wild type and BT-IgSF-deficient males [9]. Interestingly, AMPA receptors have been implicated in aggressive and social behaviors [29, 30]. Mice deficient for the GluR1 subunit-containing AMPA receptors display reduced intermale aggression [31]. As already pointed out above, the synaptic stabilization of AMPARs is promoted through the dual interaction of PSD95 with BT-IgSF (IgSF11) and AMPARs. The loss of BT-IgSF in mice results in decreased excitatory synaptic strength in dentate gyrus granule cells and decreased long-term potentiation at SC-CA1 synapses in the hippocampus [7]. The synaptic stabilization of AMPARs is promoted by the interaction of IgSF11 with PSD-95 and AMPARs and loss of IgSF11 in mice results in decreased excitatory synaptic strength in DG granule cells and decreased LTP at SC-CA1 synapses in the hippocampus [7]. Therefore, the increased aggression of BT-IgSF-deficient mice towards an intruder may be related to altered AMPA receptor activity. Indirectly, perturbed gap-junction mediated communication between astrocytes in the hippocampus and cortex of BT-IgSF-deficient mice may interfere with neuronal network properties influencing behavioral performance. Furthermore, traits of aggression and anger are often observed in patients with major depressive disorder, dementia, and other neuropsychiatric disorders [3234]. However, to our knowledge, mutations in the BT-IgSF gene have not been associated with any of these conditions. Disturbed emotional regulation, such as abnormally low levels of anxiety, indicated by the behavior of BT-IgSF-deficient mice in open spaces may result in or reflect excessive aggression. An overall interpretation of the phenotype of BT-IgSF-deficient mice may indicate the reduced ability to quickly adjust to changes in the environment.

Supporting information

S1 Data

(XLSX)

S2 Data

(XLSX)

S3 Data

(XLSX)

S4 Data

(XLSX)

Acknowledgments

The authors gratefully acknowledge expert technical assistance by Karla Sowa and Karola Bach for mouse breeding. The critical reading of Elijah Löwenstein (MDC) is greatly acknowledged. FGR is an emeritus professor at the MDC. FGR thanks Dr Carmen Birchmeier (MDC, Berlin) for generous support and insightful discussions.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Suzu S, Hayashi Y, Harumi T, Nomaguchi K, Yamada M, Hayasawa H, et al. Molecular cloning of a novel immunoglobulin superfamily gene preferentially expressed by brain and testis. BiochemBiophysResCommun. 2002;296: 1215–1221. doi: 10.1016/s0006-291x(02)02025-9 [DOI] [PubMed] [Google Scholar]
  • 2.Eom DS, Inoue S, Patterson LB, Gordon TN, Slingwine R, Kondo S, et al. Melanophore Migration and Survival during Zebrafish Adult Pigment Stripe Development Require the Immunoglobulin Superfamily Adhesion Molecule Igsf11. PLoSGenet. 2012;8: e1002899. doi: 10.1371/journal.pgen.1002899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Harada H, Suzu S, Hayashi Y, Okada S. BT-IgSF, a novel immunoglobulin superfamily protein, functions as a cell adhesion molecule. JCell Physiol. 2005;204: 919–926. doi: 10.1002/jcp.20361 [DOI] [PubMed] [Google Scholar]
  • 4.Rathjen FG. The CAR group of Ig cell adhesion proteins–Regulators of gap junctions? 2020; 1–11. doi: 10.1002/bies.202000031 [DOI] [PubMed] [Google Scholar]
  • 5.Katoh MM, Katoh MM. IGSF11 gene, frequently up-regulated in intestinal-type gastric cancer, encodes adhesion molecule homologous to CXADR, FLJ22415 and ESAM. Int J Oncol. 2003;23: 525–531. [PubMed] [Google Scholar]
  • 6.Wang J, Wu G, Manick B, Hernandez V, Renelt M, Erickson C, et al. VSIG-3 as a ligand of VISTA inhibits human T-cell function. Immunology. 2018. doi: 10.1111/imm.13001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jang S, Oh D, Lee Y, Hosy E, Shin H, van Riesen C, et al. Synaptic adhesion molecule IgSF11 regulates synaptic transmission and plasticity. Nat Neurosci. 2015;19: 84–93. doi: 10.1038/nn.4176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hayano Y, Ishino Y, Hyun JH, Orozco CG, Steinecke A, Potts E, et al. IgSF11 homophilic adhesion proteins promote layer-specific synaptic assembly of the cortical interneuron subtype. Sci Adv. 2021;7. doi: 10.1126/sciadv.abf1600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pelz L, Purfürst B, Rathjen FG. The cell adhesion molecule BT-IgSF is essential for a functional blood-testis barrier and male fertility in mice. J Biol Chem. 2017;292: 21490–21503. doi: 10.1074/jbc.RA117.000113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kim H, Takegahara N, Walsh MC, Middleton SA, Yu J, Shirakawa J, et al. IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95. Bone Res. 2020;8: 5. doi: 10.1038/s41413-019-0080-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ahi EP, Sefc KM. A gene expression study of dorso-ventrally restricted pigment pattern in adult fins of Neolamprologus meeli, an African cichlid species. PeerJ. 2017;5: e2843. doi: 10.7717/peerj.2843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Singh AP, Nusslein-Volhard C. Zebrafish stripes as a model for vertebrate colour pattern formation. Curr Biol. 2015;25: R81–R92. doi: 10.1016/j.cub.2014.11.013 [DOI] [PubMed] [Google Scholar]
  • 13.Chen B, Zhu G, Yan A, He J, Liu Y, Li L, et al. IGSF11 is required for pericentric heterochromatin dissociation during meiotic diplotene. PLoS Genet. 2021;17. doi: 10.1371/journal.pgen.1009778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pelz L., Dossou L., Kompier N., Jüttner R. S, G., Meyer N., Lowenstein E. D., et al. The IgCAM BT-IgSF (IgSF11) is essential for connexin43-mediated astrocyte-astrocyte and ependymal cell-cell coupling. Biorxiv doi.org/101101/20220617496568. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Li MWM, Mruk DD, Lee WM, Cheng CY. Connexin 43 is critical to maintain the homeostasis of the blood-testis barrier via its effects on tight junction reassembly. Proc Natl Acad Sci U S A. 2010;107: 17998–18003. doi: 10.1073/pnas.1007047107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Watanabe M, Kondo S. Changing clothes easily: connexin41.8 regulates skin pattern variation. Pigment Cell Melanoma Res. 2012;25: 326–330. doi: 10.1111/j.1755-148X.2012.00984.x [DOI] [PubMed] [Google Scholar]
  • 17.Irion U, Frohnhofer HG, Krauss J, Colak Champollion T, Maischein H-M, Geiger-Rudolph S, et al. Gap junctions composed of connexins 41.8 and 39.4 are essential for colour pattern formation in zebrafish. Elife. 2014;3: e05125. doi: 10.7554/eLife.05125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Haffter P, Odenthal J, Mullins MC, Lin S, Farrell MJ, Vogelsang E, et al. Mutations affecting pigmentation and shape of the adult zebrafish. Dev Genes Evol. 1996;206: 260–276. doi: 10.1007/s004270050051 [DOI] [PubMed] [Google Scholar]
  • 19.Watanabe M, Iwashita M, Ishii M, Kurachi Y, Kawakami A, Kondo S, et al. Spot pattern of leopard Danio is caused by mutation in the zebrafish connexin41.8 gene. EMBO Rep. 2006;7: 893–897. doi: 10.1038/sj.embor.7400757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wersinger SR, Ginns EI, O’Carroll AM, Lolait SJ, Young WS. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol Psychiatry. 2002;7: 975–984. doi: 10.1038/sj.mp.4001195 [DOI] [PubMed] [Google Scholar]
  • 21.Montag-Sallaz M, Schachner M, Montag D. Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1. MolCell Biol. 2002;22: 7967–7981. doi: 10.1128/MCB.22.22.7967-7981.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bhattacharya S, Herrera-Molina R, Sabanov V, Ahmed T, Iscru E, Stöber F, et al. Genetically Induced Retrograde Amnesia of Associative Memories After Neuroplastin Ablation. Biol Psychiatry. 2017;81: 124–135. doi: 10.1016/j.biopsych.2016.03.2107 [DOI] [PubMed] [Google Scholar]
  • 23.Montag-Sallaz M, Montag D. Severe cognitive and motor coordination deficits in tenascin-R-deficient mice. Genes Brain Behav. 2003;2: 20–31. doi: 10.1034/j.1601-183x.2003.00003.x [DOI] [PubMed] [Google Scholar]
  • 24.Montag-Sallaz M, Montag D. Learning-induced arg 3.1/arc mRNA expression in the mouse brain. Learn Mem. 2003;10: 99–107. doi: 10.1101/lm.53403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Comery TA, Martone RL, Aschmies S, Atchison KP, Diamantidis G, Gong X, et al. Acute γ-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci. 2005;25: 8898–8902. doi: 10.1523/JNEUROSCI.2693-05.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer’s disease-like pathology. Nat Med. 2008;14: 1106–1111. doi: 10.1038/nm.1872 [DOI] [PubMed] [Google Scholar]
  • 27.Jacobsen JS, Wu C-C, Redwine JM, Comery TA, Arias R, Bowlby M, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2006;103: 5161–5166. doi: 10.1073/pnas.0600948103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Higashine K, Hashimoto K, Tsujimoto E, Oishi Y, Hayashi Y, Miyamoto Y. Promotion of differentiation in developing mouse cerebellar granule cells by a cell adhesion molecule BT-IgSF. Neurosci Lett. 2018;686: 87–93. doi: 10.1016/j.neulet.2018.08.049 [DOI] [PubMed] [Google Scholar]
  • 29.Shimizu K, Kurosawa N, Seki K. The role of the AMPA receptor and 5-HT(3) receptor on aggressive behavior and depressive-like symptoms in chronic social isolation-reared mice. Physiol Behav. 2016;153: 70–83. doi: 10.1016/j.physbeh.2015.10.026 [DOI] [PubMed] [Google Scholar]
  • 30.Araki R, Ago Y, Hasebe S, Nishiyama S, Tanaka T, Oka S, et al. Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice. Int J Neuropsychopharmacol. 2014;17: 883–893. doi: 10.1017/S1461145713001582 [DOI] [PubMed] [Google Scholar]
  • 31.Vekovischeva OY, Aitta-Aho T, Echenko O, Kankaanpää A, Seppälä T, Honkanen A, et al. Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice. Genes Brain Behav. 2004;3: 253–265. doi: 10.1111/j.1601-1848.2004.00075.x [DOI] [PubMed] [Google Scholar]
  • 32.Beier AM, Lauritzen L, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, et al. Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder. J Psychiatr Res. 2014;57: 133–140. doi: 10.1016/j.jpsychires.2014.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Koh KB, Kim CH, Choi EH, Lee Y, Seo WY. Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. J Clin Psychiatry. 2012;73: e574–9. doi: 10.4088/JCP.11m07342 [DOI] [PubMed] [Google Scholar]
  • 34.Ballard C, Corbett A. Agitation and aggression in people with Alzheimer’s disease. Curr Opin Psychiatry. 2013; 26:252–259. doi: 10.1097/YCO.0b013e32835f414b [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Jamuna Subramaniam

6 Oct 2022

PONE-D-22-21240Lack of the Ig cell adhesion molecule BT-IgSF (IgSF11) induced behavioral changes in the open maze, water maze and resident intruder test

PLOS ONE

Dear Dr. Montag,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

  • Address any conflicts between the reviews so that it's clear which advice the authors should follow

  • Provide specific feedback from your evaluation of the manuscript

Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact.

For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. 

==============================

Please submit your revised manuscript by Nov 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jamuna Subramaniam, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Montag et al., have demonstrated the impact of BT-IgSF in various behaviour paradigms. It is a novel finding and has implications in understanding diseases induced by this particular mutation. They authors conclude by stating that specific behaviours are modified by the lack of BT-IgSF and demonstrate a contribution of BT-IgSF to network functions, which they have not shown it experimentally. The manuscript will be strengthened if they could show the below mentioned points.

1.The authors have mentioned about the role of AMPAR in the behavioural abnormalities they have observed in this mouse model. However, they should have showed using electrophysiology or Immunohistochemistry or immunoblot techniques. Furthermore, given the role of AMPARs in memory formation and lack of it, they should have done one or two experiments on the impact of these mutations on basal synaptic transmissions.

2.The authors extrapolate the results to altered function of gap junction mediated communication between astrocytes and the hippocampus. However, the authors should have demonstrated these hypotheses using IHC.

3.Does this mutation impact sociability in these mice?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: James Chelliah

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jan 6;18(1):e0280133. doi: 10.1371/journal.pone.0280133.r002

Author response to Decision Letter 0


9 Nov 2022

We thank for the overall positive evaluation of our manuscript.

Referee 1 asked for additional experiments/information on

1) the AMPA receptor (electrophysiology or immunohistochemistry) and

2) on gap junctional communication between astrocytes (immunohistochemistry)

in the absence of BT-IgSF

3) whether this mutation impacts sociability

We agree with referee 1 that such data strongly support our interpretations of the behavioral deficits in the absence of BT-IgSF which are drawn in our manuscript. Indeed, such data on the AMPA receptor including electrophysiological measurements and immunohistochemistry in the absence of BT-IgSF (also termed IgSF11) have already been published by Jang et al. 2015 (ref. #7). Furthermore, studies on gap junctional communication between astrocytes including immunohistochemistry, biochemistry and biocytin spreading in the cortex and hippocampus in the absence of BT-IgSF have been recently published by Pelz et al., 2022 (ref. #14). Therefore, now we have cited and discussed these published data in detail in the conclusion paragraph of the revised version of our manuscript. We feel that these additions improved our manuscript in that they illustrate the contribution of BT-IgSF to network functions in the nervous system. The increased aggression of BT-IgSF11-/- males reported in our manuscript dominates sociability with littermates and their infertility affects interaction with females.

All changes that we added are marked in red in our manuscript file "Revised Manuscript with Track Changes PONE-D-22-21240". All original data are now provided in supplementary files.

We hope very much that with these additions our manuscript is now acceptable for publication in PLOS ONE.

Attachment

Submitted filename: Response to Reviewers PONE-D-22-21240.docx

Decision Letter 1

Jamuna Subramaniam

21 Dec 2022

Lack of the Ig cell adhesion molecule BT-IgSF (IgSF11) induced behavioral changes in the open maze, water maze and resident intruder test

PONE-D-22-21240R1

Dear Dr. Montag,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jamuna Subramaniam, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

I am glad to state that your manuscript is accepted based on the correlation between Bt-IGsF1 deficiency altering behaviors in these mice.

Reviewers' comments:

Acceptance letter

Jamuna Subramaniam

27 Dec 2022

PONE-D-22-21240R1

Lack of the Ig cell adhesion molecule BT-IgSF (IgSF11) induced behavioral changes in the open maze, water maze and resident intruder test

Dear Dr. Montag:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jamuna Subramaniam

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    S2 Data

    (XLSX)

    S3 Data

    (XLSX)

    S4 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers PONE-D-22-21240.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES